Vir Biotechnology, Inc. (VIR)
8.49
-0.38
(-4.28%)
USD |
NASDAQ |
Nov 20, 15:00
Vir Biotechnology 30-Day Average Daily Volume : 2.612M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.612M |
| November 18, 2026 | 2.651M |
| November 17, 2026 | 2.698M |
| November 16, 2026 | 2.668M |
| November 13, 2026 | 2.547M |
| November 12, 2026 | 2.064M |
| November 11, 2026 | 2.081M |
| November 10, 2026 | 2.096M |
| November 09, 2026 | 2.105M |
| November 06, 2026 | 1.914M |
| November 05, 2026 | 1.888M |
| November 04, 2026 | 1.860M |
| November 03, 2026 | 1.822M |
| November 02, 2026 | 1.832M |
| October 30, 2026 | 1.835M |
| October 29, 2026 | 2.026M |
| October 28, 2026 | 2.039M |
| October 27, 2026 | 2.057M |
| October 26, 2026 | 2.067M |
| October 23, 2026 | 2.075M |
| October 22, 2026 | 2.088M |
| October 21, 2026 | 2.117M |
| October 20, 2026 | 2.144M |
| October 19, 2026 | 2.153M |
| October 16, 2026 | 2.148M |
| Date | Value |
|---|---|
| October 15, 2026 | 2.176M |
| October 14, 2026 | 2.229M |
| October 13, 2026 | 2.229M |
| October 12, 2026 | 2.272M |
| October 09, 2026 | 2.296M |
| October 08, 2026 | 2.289M |
| October 07, 2026 | 2.261M |
| October 06, 2026 | 2.241M |
| October 05, 2026 | 2.213M |
| October 02, 2026 | 2.167M |
| October 01, 2026 | 2.130M |
| September 30, 2026 | 2.113M |
| September 29, 2026 | 2.105M |
| September 28, 2026 | 2.101M |
| September 25, 2026 | 2.089M |
| September 24, 2026 | 2.093M |
| September 23, 2026 | 2.056M |
| September 22, 2026 | 2.040M |
| September 21, 2026 | 2.028M |
| September 18, 2026 | 2.035M |
| September 17, 2026 | 1.888M |
| September 16, 2026 | 1.877M |
| September 15, 2026 | 1.864M |
| September 14, 2026 | 1.829M |
| September 11, 2026 | 1.805M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Moderna, Inc. | 14.61M |
| Vaxcyte, Inc. | 1.949M |
| Oncolytics Biotech, Inc. | 1.369M |
| Sangamo Therapeutics, Inc. | 1.137M |
| Sarepta Therapeutics, Inc. | 2.419M |